Fidelma P Dunne
Overview
Explore the profile of Fidelma P Dunne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newman C, Dunne F
Obstet Gynecol
. 2024 Aug;
144(5):660-669.
PMID: 39208454
Metformin is a commonly used drug in the treatment of type 2 diabetes and has been used to treat gestational diabetes since the 1970s. In pregnancy, its proven benefits include...
2.
Newman C, Kinsella S, Rooney P, Bromley J, Connor R, Gajewska K, et al.
Diabet Med
. 2024 Aug;
41(12):e15429.
PMID: 39160771
Aims: To undertake a Priority Setting Partnership (PSP), identifying the most important unanswered questions in type 1 diabetes in Ireland and the United Kingdom and to compare these to priorities...
3.
Islam M, Lyons C, Griffin T, Hamon S, Dunne F, OShea P
Ann Clin Biochem
. 2023 Aug;
61(2):133-142.
PMID: 37626439
Background: Adopting the WHO protocol for glucose analysis is arguably impractical in the routine clinical setting. Deviations may develop due to a lack of understanding regarding the impact of glycolysis...
4.
Newman C, Rabbitt L, Ero A, Dunne F
Drugs
. 2023 Jun;
83(11):985-999.
PMID: 37354354
Metformin is used worldwide in the treatment of type 2 diabetes and has been used in the treatment of diabetes in pregnancy since the 1970s. It is highly acceptable to...
5.
Bogdanet D, Castillo M, Doheny H, Dervan L, Luque-Fernandez M, Halperin J, et al.
Diabet Med
. 2023 Apr;
40(9):e15121.
PMID: 37078256
Aims: Gestational diabetes (GDM) is associated with the development of postpartum (PP) glucose intolerance. Plasma glycated CD59 (pGCD59) is an emerging biomarker for the detection of hyperglycaemia. The aim of...
6.
Griffin T, OShea P, Smyth A, Islam M, Wall D, Ferguson J, et al.
BMJ Open Diabetes Res Care
. 2023 Apr;
9(1).
PMID: 37077135
Introduction: This study aimed to determine the prevalence of diabetic kidney disease (DKD) and rapid renal function decline and to identify indices associated with this decline among adults attending a...
7.
Newman C, Ero A, Dunne F
Front Endocrinol (Lausanne)
. 2023 Jan;
13:1109825.
PMID: 36714590
Introduction: Pregestational diabetes (PGDM) is an increasingly common and complex condition that infers risk to both mother and infant. To prevent serious morbidity, strict glycaemic control is essential. The aim...
8.
Ferry P, Dunne F, Meagher C, Lennon R, Egan A, Newman C
Diabet Med
. 2022 Nov;
40(3):e15014.
PMID: 36408687
Introduction: Type 1 diabetes mellitus occurs in one in every 275 pregnancies and can result in increased morbidity and mortality for both mother and baby. Several pregnancy complications can be...
9.
Bogdanet D, Castillo M, Doheny H, Dervan L, Luque-Fernandez M, Halperin J, et al.
Acta Diabetol
. 2022 Oct;
60(2):211-223.
PMID: 36309618
Aim: Even though most pregnancies are uneventful, occasionally complications do occur. Gestational diabetes is linked to an increased risk of adverse pregnancy outcomes. Early identification of women at risk of...
10.
Egan A, Dunne F
Nat Rev Endocrinol
. 2022 Oct;
18(12):723-724.
PMID: 36266574
No abstract available.